Argenx, a global immunology company dedicated to improving the lives of individuals with severe autoimmune diseases, has announced that it will host a conference call and audio webcast on Thursday, May 9, 2024, at 2:30 PM CET (8:30 AM ET) to discuss its first quarter 2024 financial results and provide a business update. The webcast of the live call can be accessed on the Investors section of the Argenx website at
To join the conference call, participants can use the following dial-in numbers: Belgium +32 800 50 201, France +33 800 943355, Netherlands +31 207951090, United Kingdom +44800358-